Crossmark

Novel immunohistochemical assay utilizing the INSM1 (SP493) antibody demonstrates high specificity and sensitivity in detecting primary neuroendocrine lung neoplasms

Crossref DOI link: https://doi.org/10.1186/s13000-025-01724-0

Published Online: 2025-10-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dvorak, Katerina

Gomez, Alexander

Sainz, Rafael
Funding

Funding for this research was provided by:

Roche
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 25 March 2025

Accepted: 27 September 2025

First Online: 16 October 2025

Declarations

:

: All authors are emplyee of Roche Tissue Diagnostics.

Document is current

Any future updates will be listed below